You are here: Home » News-CM » Companies » News
Business Standard

Dai-ichi Karkaria announces conclusion of agreement with GVK Bio & Inogent

Capital Market 

Pares stake in Inogent

announced that pursuant to the Call Option under the Joint Venture and Shareholders Agreement among GVK Biosciences (GVK Bio), (the Company) and Inogent Laboratories (Inogent), dated 14 October 2005, GVK Bio has acquired balance 9,87,500 equity shares (6.12% of voting powers) of Inogent from the Company on 11 July 2014, at a consideration aggregating to Rs. 8.97 crore.

Accordingly, the shareholding of the Company in Inogent after the acquisition will be NIL and the Agreement shall be treated as concluded.

Powered by Capital Market - Live News

First Published: Mon, July 14 2014. 15:29 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU